Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

globenewswire.com
INO Mentioned as a key company in the HPV testing and Pap test market reports, indicating its involvement in the sector but without specific performance details. REGN Listed as a key company in HPV testing and Pap test market reports, suggesting involvement in the sector without specific performance indicators. VIR Identified as a key company in the HPV testing and Pap test market, implying participation in the sector without specific performance data. MRK Mentioned as a key player in the HPV testing and Pap test market and HPV16+ Anogenital Cancers market, indicating presence but no specific performance details. AMGN While not explicitly named, Amgen is a major player in the broader healthcare and diagnostics space, and its involvement in HPV testing is plausible given the market trends. However, the article does not provide specific details. ABT Listed as a key company in both Molecular Diagnostics and In-vitro Diagnostics markets, indicating its broad presence in the relevant sectors without specific performance details. QGEN Identified as a key company in both Molecular Diagnostics and In-vitro Diagnostics markets, implying its role in the sector but without specific performance data. BDX Mentioned as a key company in Molecular Diagnostics and In-vitro Diagnostics markets, indicating its presence in the sector without specific performance details. TMO Listed as a key company in both Molecular Diagnostics and In-vitro Diagnostics markets, suggesting its involvement in the sector without specific performance data. DHR Mentioned as a key company in the Molecular Diagnostics market and its subsidiary Beckman Coulter, Inc. in the In-vitro Diagnostics market, indicating presence without specific performance details. MYGN Identified as a key company in the Molecular Diagnostics market, implying participation in the sector but without specific performance data. ILMN Listed as a key company in both Molecular Diagnostics and In-vitro Diagnostics markets, suggesting its involvement in the sector without specific performance data. EXAS Mentioned as a key company in the Molecular Diagnostics market, indicating its presence in the sector without specific performance details. BIO Listed as a key company in the In-vitro Diagnostics market, suggesting its involvement in the sector without specific performance data.

Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight

The HPV testing and Pap test market is witnessing significant growth due to the rising prevalence of cervical cancer and increasing awareness about early screening and diagnosis. Government-led screening initiatives, improving healthcare infrastructure, and the growing adoption of molecular diagnostic technologies are further supporting market expansion. In addition, the introduction of self-sampling HPV tests and AI-assisted cytology platforms is enhancing the accessibility and accuracy of screening procedures.

DelveInsight’s HPV Testing and Pap Test Market Insights report provides the current and forecast market analysis, individual leading HPV testing and Pap test companies’ market shares, challenges, HPV testing and Pap test market drivers, barriers, trends, and key HPV testing and Pap test companies in the market.

HPV Testing and Pap Test Market Summary

To read more about the latest highlights related to the HPV testing and Pap test market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/hpv-testing-and-pap-test-market

Key Factors Contributing to the Rise in Growth of the HPV Testing and Pap Test Market

Get a sneak peek at the HPV testing and Pap test market dynamics @ HPV Testing and Pap Test Market Trends

Regional HPV Testing and Pap Test Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the HPV testing and Pap test market, get a snapshot of the HPV Testing and Pap Test Market Share

Recent Developmental Activities in the HPV Testing and Pap Test Market

What are HPV Testing and Pap Test?

HPV testing and the Pap test are important cervical cancer screening methods used to detect early signs of disease in the cervix. HPV testing identifies the presence of high-risk types of the human papillomavirus (HPV), a common sexually transmitted infection that is responsible for most cervical cancer cases. This test helps determine whether a person is at increased risk of developing cervical abnormalities or cancer in the future. In contrast, the Pap test, also known as a Pap smear, examines cervical cells under a microscope to detect abnormal or precancerous changes that may eventually progress to cervical cancer if left untreated. While the HPV test focuses on detecting the virus that can cause cancer, the Pap test looks for actual cellular changes already occurring in the cervix. These tests are often used together in routine cervical cancer screening programs to improve early detection, enable timely treatment, and reduce cervical cancer-related mortality.

HPV Testing and Pap Test Market Assessment

Which MedTech key players in the HPV testing and Pap test market are set to emerge as the trendsetter explore @ HPV Testing and Pap Test Market Analysis

Table of Contents

Interested in knowing the HPV testing and Pap test market share by 2034? Click to get a snapshot of the HPV Testing and Pap Test Market Size

Related Reports

Human Papillomavirus Market

Human Papillomavirus Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key HPV companies, including Inovio Pharmaceuticals, Inc., ISA Pharmaceuticals, Regeneron Pharmaceuticals, Barinthus Biotherapeutics, pHion Therapeutics, Vir Biotechnology, Inc., Antiva Biosciences, Toragen, Inc., Precigen, Inc, Merck Sharp & Dohme LLC, ViMREX GmbH, and others.

Human Papillomavirus Clinical Trial Analysis

Human Papillomavirus Pipeline Insight – 2026 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key HPV companies, including ng Inovio Pharmaceuticals, Inc., ISA Pharmaceuticals, Regeneron Pharmaceuticals, Barinthus Biotherapeutics, pHion Therapeutics, Vir Biotechnology, Inc., Antiva Biosciences, Toragen, Inc., Precigen, Inc, Merck Sharp & Dohme LLC, ViMREX GmbH, and others.

HPV16+ Anogenital Cancers Market

HPV16+ Anogenital Cancers Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key HPV16+ anogenital cancers companies including PDS Biotechnology Corp., Merck, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Vaccibody AS, Roche, Inovio Pharmaceuticals, Transgene, Advaxis, and others.

Molecular Diagnostics Market

Molecular Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key molecular diagnostics companies, including Hoffmann-La Roche Ltd., Hologic, Inc., bioMérieux SA, Abbott, QIAGEN, BD, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher, Myriad Genetics, Inc., Agilent Technologies Inc., Illumina Inc., DiaSorin Inc., MDxHealth, Genetic Signatures, Biocartis, Exact Sciences Corporation, Amoy Diagnostics Co. Ltd., Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, and others.

In-vitro Diagnostics Market

In-vitro Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key in-vitro diagnostics companies, including F. Hoffmann-La Roche Ltd, Abbott, FUJIFILM Corporation, Sysmex Corporation, Siemens Healthcare GmbH, BD, Seegene Inc, Beckman Coulter, Inc ( Danaher Corporation), QIAGEN, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Cisbio (PerkinEemer), ARKRAY, Inc, Ortho Clinical Diagnostics, ACON Laboratories, Inc., Teco Diagnostics, EKF Diagnostics, Besurence GmbH, Savyon Diagnostics, HORIBA, Ltd., Palliance AB, Sugentech, Inc, Cypress Diagnostics, Salignostics, The Menarini Group, DxGen Corp, HUMAN, Nova Biomedical, Asahi Kasei Pharma Corporation, Agilent Technologies, Inc., and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.